DAEWOONG PHARMACEUTICAL CO., LTD.
DEAD

Serial Number

77004855

Owner

DAEWOONG CO., LTD.

Attorney

Kelly Phair McCarthy

First Use Date

May 14, 2002

Filing Date

Sep 21, 2006

Add to watchlist:

No watchlists yet
View on USPTO

DAEWOONG PHARMACEUTICAL CO., LTD. Trademark

Serial Number: 77004855 • Registration: 3966537

DAEWOONG PHARMACEUTICAL CO., LTD. is a trademark filed by DAEWOONG CO., LTD. on September 21, 2006. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

DAEWOONG CO., LTD. (17 trademarks)

244, Galmachi-ro,

Entity Type: 03

Trademark Details

Filing Date

September 21, 2006

Registration Date

May 24, 2011

First Use Anywhere

May 14, 2002

First Use in Commerce

October 1, 2010

Published for Opposition

June 24, 2008

Cancellation Date

December 29, 2017

Goods & Services

Pharmaceutical preparations, namely, acetaminophen, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non surgical use, antacids, bactericides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; dietary and nutritional supplements; medicated skin lotions, bandages for skin wounds, vitamins; biological preparations for medical purposes; all purpose disinfecting and deodorizing preparations; pharmaceutical preparations for use in cardiovascular treatment; diagnostic agents for medical purposes; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations to prevent swelling in the legs; pharmaceutical preparations for treating respiratory diseases and asthma; pharmaceutical preparations for the treatment of erectile dysfunction; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; processed food adapted for medical purposes; plant extracts adapted for use in the treatment of the central nervous system, diabetes, skin disorders, wounds, eye diseases and conditions, swelling in the legs, respiratory diseases, asthma, erectile dysfunction, cardiovascular conditions, heart rhythm disorders and infectious diseases; plant extracts adapted for use in chemotherapy; veterinary preparations for treatment of intestinal bacteria in mammals; veterinary preparations, namely, vaccines; sanitary preparations for medical use

Pharmaceutical sales promotion for others; providing business information for pharmaceuticals; business management assistance on pharmaceuticals; market research; market study; advertising services; arranging of pharmaceutical sale, namely, procuring of contracts for the purchase and sale of pharmaceuticals, retail services by direct solicitation by sales agents in the field of pharmaceuticals; export-import agency; retail store services in the field of health supplements, retail services by direct solicitation by sales agents in the field of health supplements; retail store services in the field of cosmetics, retail services by direct solicitation by sales agents in the field of cosmetics; and procurement services, namely, purchasing pharmaceuticals for others

Medical clinics; pharmaceutical advice; preparation and dispensing of pharmaceuticals; technology services on selecting medicines, namely, interactive medical monitoring and alert services for reminding clients of medical information, namely, medicinal dosage, allergic sensitivity and prescription refills; providing medical information about medical equipment, devices and pharmaceutical preparations; clinical pathology services for the diagnosis and treatment of disease; medical assistance services; medical testing service; medical and health care, namely, ambulant medical care; cosmetic analysis; rental of medical equipment; rental of sanitary equipment, namely, clean chambers for sanitary purposes, urinals for sanitary fixtures, hand washing basins and bowls for sanitary installations and water pipes for sanitary installations

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 29, 2017 C8..
REGISTERED-PRINCIPAL REGISTER
May 24, 2011 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 20, 2011 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Apr 19, 2011 REGV
ASSIGNED TO LIE
Apr 19, 2011 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 5, 2011 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2011 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Mar 14, 2011 SUPC
SOU EXTENSION 5 GRANTED
Mar 14, 2011 EX5G
USE AMENDMENT FILED
Mar 10, 2011 IUAF
SOU EXTENSION 5 FILED
Mar 10, 2011 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 10, 2011 EEXT
TEAS STATEMENT OF USE RECEIVED
Mar 10, 2011 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2010 EXRA
SOU EXTENSION 4 GRANTED
Sep 14, 2010 EX4G
SOU EXTENSION 4 FILED
Sep 13, 2010 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 13, 2010 EEXT
SOU EXTENSION 3 GRANTED
Mar 11, 2010 EX3G
SOU EXTENSION 3 FILED
Mar 4, 2010 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 4, 2010 EEXT
SOU EXTENSION 2 GRANTED
Sep 24, 2009 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 24, 2009 AITU
SOU EXTENSION 2 FILED
Sep 14, 2009 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 14, 2009 EEXT
SOU EXTENSION 1 GRANTED
Mar 11, 2009 EX1G
SOU EXTENSION 1 FILED
Mar 11, 2009 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 11, 2009 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 16, 2008 NOAM
PUBLISHED FOR OPPOSITION
Jun 24, 2008 PUBO
NOTICE OF PUBLICATION
Jun 4, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 22, 2008 PREV
ASSIGNED TO LIE
May 16, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 9, 2008 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Apr 21, 2008 GPRN
PRIORITY ACTION E-MAILED
Apr 21, 2008 GPRA
PRIORITY ACTION WRITTEN
Apr 21, 2008 CPRA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 21, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 28, 2008 PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 18, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 4, 2008 PREV
ASSIGNED TO LIE
Jan 4, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2007 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 19, 2007 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 19, 2007 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 19, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 19, 2007 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 12, 2007 TROA
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 2, 2007 GNFN
FINAL REFUSAL E-MAILED
Oct 2, 2007 GNFR
FINAL REFUSAL WRITTEN
Oct 2, 2007 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 21, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 21, 2007 TROA
NON-FINAL ACTION E-MAILED
Feb 22, 2007 GNRT
NON-FINAL ACTION WRITTEN
Feb 22, 2007 CNRT
ASSIGNED TO EXAMINER
Feb 9, 2007 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 17, 2007 TCCA
NOTICE OF DESIGN SEARCH CODE MAILED
Sep 28, 2006 MDSC
NEW APPLICATION ENTERED
Sep 27, 2006 NWAP